Home > News > 87/Physiologist led triage of AliveCor device monitoring for cardiology outpatients
Read Time: 2 mins

87/Physiologist led triage of AliveCor device monitoring for cardiology outpatients

Published Online: October 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr87
Authors: J Kakarla (Presenting Author) - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK; A Brown - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK; P Surtees - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK; I Matthews - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK; C Runnett - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK; DP Ripley - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK; H Thomas - Northumbria Healthcare NHS Foundation Trust, Northumbria, UK
Quick Links:
Article Information

Recording significant arrhythmia in patients with palpitations and pre-syncope can be challenging given the unpredictable onset and duration of symptoms. Conventional rhythm monitoring devices are time limited, resource intensive and suffer from low diagnostic yield. Patient activated smartphone connected devices that record rhythm strips offer promise as an affordable and effective rhythm monitoring device. The AliveCor heart monitor has shown efficacy in screening for atrial fibrillation and promise in arrhythmia screening in patients presenting to the emergency department (Reed et al., 2018). There is limited retrospective evidence of its utility as a rhythm monitoring tool in outpatients with palpitations (Newham and Tayebjee, 2017). We present a prospective evaluation of physiologist led triage of AliveCor as a prolonged rhythm monitoring alternative for referrals from cardiology clinic.

We initiated physiologist led triage of all rhythm monitoring referrals from cardiology clinic for assessment of palpitations, pre-syncope or syncope (with preceding palpitations or pre-syncope). Eligible patients required symptoms lasting at least 30 seconds and occurring less frequently than twice weekly but more than three-monthly. Additionally, patients had to be able to use a compatible smartphone during the symptoms. Following the screening, patients attended a short appointment to collect the device and receive recording instruction. Recordings were transmitted to a dedicated secure e-mail account which was reviewed daily by a physiologist. The patient kept the device until 3 normal recordings or 1 pathological diagnostic rhythm was received over a maximum of 3 months. A final report was issued to the referring consultant.

Forty-six patients completed monitoring (23 female, age median 50 years, IQR 39–65) over an 18-month period. 33 had palpitations, 11
pre-syncope and 2 palpitations and syncope. 63% had previous
prolonged non-diagnostic monitoring and 4 had previous smart-watch detected “arrhythmia” (2 bradycardia, 2 tachycardia). Each patient made a median of 5 recordings (IQR 3–9). The median time to diagnosis was 5 days (IQR 1–15). 14 (30%) patients recorded a significant arrhythmia (AF [9], SVT [4], NSVT [1]). The remainder recorded benign rhythms (sinus in 25 [54%], ectopy in 5 [11%]) and 2 had no symptoms in the 3-month period. All patients received a diagnosis with no further rhythm monitoring required. Physiologists spent an estimated 1 minute in analysis per Alivecor rhythm strip within the remote monitoring clinic as opposed to 15 minutes per 24-hour ambulatory monitor analysis.

Physiologist led triage and analysis of AliveCor device monitoring in selected patients with palpitations, pre-syncope and syncope resulted in a universal diagnosis of a spectrum of normal, atrial and ventricular rhythms. The time to diagnosis was short and appears to be a more time and cost-effective strategy than conventional monitoring.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
43/Cardiac tamponade as a complication of transseptal puncture: associations and operatordependent variables during left atrial ablation at Barts Heart Centre
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; K Mahtani - St Bartholomew’s Hospital, London; C Butcher - St Bartholomew’s Hospital, London; N Ahluwalia - St Bartholomew’s Hospital, London; M Finlay - St Bartholomew’s Hospital, London; S Honarbakhsh - St Bartholomew’s Hospital, London; A Creta - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; V Sawhney - St Bartholomew’s Hospital, London; V Ezzat - St Bartholomew’s Hospital, London; MJ Earley - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; MD Lowe - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; SY Ahsan - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; O Sega - St Bartholomew’s Hospital, London Read Time: 2 mins

European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr43

Introduction: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the incidence and predictors of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our centre from 2016-2020. Methods: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinised to adjudicate TSP culpability. Adjusted multivariate […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72